Treatment outcomes of low-level viremia among adults living with HIV on dolutegravir-based first line antiretroviral therapy in Botswana

被引：0
|
作者：
Bareng, Ontlametse T. [1 ,2 ]
Moyo, Sikhulile [1 ,3 ]
Mudanga, Mbatshi [4 ]
Sebina, Kagiso [4 ]
Koofhethile, Catherine [1 ,3 ]
Choga, Wonderful [1 ,2 ]
Gobe, Irene [2 ]
Motswaledi, Modisa [2 ]
Maruapula, Docas [1 ]
Moraka, Natasha [1 ,2 ]
Musonda, Rosemary [1 ]
Nkomo, Joseph [5 ]
Ramaabya, Dinah [5 ]
Chebani, Tony [5 ]
Makuruetsa, Penny [5 ]
Makhema, Joseph [1 ,3 ]
Gaseitsiwe, Simani [1 ,3 ]
机构：
[1] Botswana Harvard Aids Inst, Gaborone, Botswana
[2] Univ Botswana, Fac Allied Hlth Profess, Dept Med Sci, Gaborone, Botswana
[3] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[4] BUMMHI, Gaborone, Botswana
[5] Minist Hlth, Gaborone, Botswana
来源：
BMJ GLOBAL HEALTH | 2023年 / 8卷 / SUPPL_10期
关键词：
D O I：
10.1136/bmjgh-2023-EDC.53
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
OA-770
引用
收藏
页码：A24 / A24
页数：1
相关论文
共 50 条
  • [31] Effect of Dolutegravir-Based First-Line Antiretroviral Therapy on Mother-to-Child Transmission of HIV Among HIV-Exposed Infants in Ethiopia: a Before-and-After Study
    Facha, Wolde
    Tadesse, Takele
    Wolka, Eskinder
    Astatkie, Ayalew
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2024, 16 : 203 - 215
  • [32] Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimens
    Chen, Guan-Jhou
    Sun, Hsin-Yun
    Chen, Ling-Ya
    Hsieh, Szu-Min
    Sheng, Wang-Hui
    Liu, Wang-Da
    Chuang, Yu-Chung
    Huang, Yu-Shan
    Lin, Kuan-Yin
    Wu, Pei-Ying
    Chang, Hsi-Yen
    Luo, Yu-Zhen
    Su, Yi-Ching
    Liu, Wen-Chun
    Chang, Sui-Fang
    Chang, Sui-Yuan
    Hung, Chien-Ching
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 60 (03)
  • [33] Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment
    Elvstam, Olof
    Medstrand, Patrik
    Yilmaz, Aylin
    Isberg, Per-Erik
    Gisslen, Magnus
    Bjorkman, Per
    PLOS ONE, 2017, 12 (07):
  • [34] Prevalence and Significance of HIV-1 Drug Resistance Mutations among Patients on Antiretroviral Therapy with Detectable Low-Level Viremia
    Li, Jonathan Z.
    Gallien, Sebastien
    Do, Tri D.
    Martin, Jeffrey N.
    Deeks, Steven
    Kuritzkes, Daniel R.
    Hatano, Hiroyu
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 5998 - 6000
  • [35] Management of low-level HIV viremia during antiretroviral therapy: Delphi consensus statement and appraisal of the evidence
    Rindi, Lorenzo Vittorio
    Zace, Drieda
    Compagno, Mirko
    Colagrossi, Luna
    Santoro, Maria Mercedes
    Andreoni, Massimo
    Perno, Carlo Federico
    Sarmati, Loredana
    SEXUALLY TRANSMITTED INFECTIONS, 2024,
  • [36] Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort
    Mondi, Annalisa
    Cozzi-Lepri, Alessandro
    Tavelli, Alessandro
    Rusconi, Stefano
    Vichi, Francesca
    Ceccherini-Silberstein, Francesca
    Calcagno, Andrea
    De Luca, Andrea
    Maggiolo, Franco
    Marchetti, Giulia
    Antinori, Andrea
    Monforte, Antonella d'Arminio
    Andreoni, M.
    Castagna, A.
    Castelli, F.
    Cauda, R.
    Di Perri, G.
    Galli, M.
    Iardino, R.
    Ippolito, G.
    Lazzarin, A.
    Marchetti, G. C.
    Rezza, G.
    von Schloesser, F.
    Viale, P.
    Ceccherini-Silberstein, F.
    Girardi, E.
    Lo Caputo, S.
    Mussini, C.
    Puoti, M.
    Perno, C. F.
    Balotta, C.
    Bandera, A.
    Bonora, S.
    Borderi, M.
    Calcagno, A.
    Capetti, A.
    Capobianchi, M. R.
    Cicalini, S.
    Cingolani, A.
    Cinque, P.
    Di Biagio, A.
    Gianotti, N.
    Gori, A.
    Guaraldi, G.
    Lapadula, G.
    Lichtner, M.
    Lo Caputo, S.
    Madeddu, G.
    Maggiolo, F.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 (01)
  • [37] Dolutegravir-based antiretroviral therapy does not reduce plasma levonorgestrel or medroxyprogesterone acetate concentrations among contraceptive users living with HIV compared with HIV-negative controls
    Ryan, Rebecca
    Mussa, Aamirah
    Bame, Bame
    Bapabi, Mbapi
    Moshashane, Neo
    Mechie, Imogen
    Ensor, Samuel
    Ndlovu, Neo
    Chakona, Shelby
    Simon, Selebaleng
    Tsuaneng, Maipelo
    Else, Laura
    Amara, Alieu
    Tatipamula, Vinay
    Dickinson, Laura
    Khoo, Saye
    Morroni, Chelsea
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 187 - 187
  • [38] Low-Level Viremia Is Associated With Clinical Progression in HIV-Infected Patients Receiving Antiretroviral Treatment
    Bernal, Enrique
    Gomez, Jose M.
    Jarrin, Inma
    Cano, Alfredo
    Munoz, Angeles
    Alcaraz, Antonia
    Imaz, Arkaitz
    Iribarren, Jose A.
    Rivero, Maria
    Arazo, Piedad
    Gutierrez, Felix
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2018, 78 (03) : 329 - 337
  • [39] Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV
    Banda, Clifford G.
    Nkosi, Dumisile
    Allen, Elizabeth
    Workman, Lesley
    Madanitsa, Mwayiwawo
    Chirwa, Marumbo
    Kapulula, Mayamiko
    Muyaya, Sharon
    Munharo, Steven
    Tarning, Joel
    Phiri, Kamija S.
    Mwapasa, Victor
    ter Kuile, Feiko O.
    Maartens, Gary
    Barnes, Karen I.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (12)
  • [40] Treatment Outcomes of Dolutegravir- Versus Efavirenz-Based Highly Active Antiretroviral Therapy Regimens Among Treatment-Naive People Living With HIV
    Mahale, Prarthana R.
    Patel, Brijalkumar S.
    Kasmani, Navsin
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
12345